Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis (PrEP).".